GALLIUM GA-68 RELITEGATIDE BREXETAN
UNII 56VJ6PVP37

Substance Identification & Data

This profile provides standardized clinical and technical data for Gallium Ga-68 Relitegatide Brexetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 56VJ6PVP37.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3061847-76-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

56VJ6PVP37

CAS Registry Number

3061847-76-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GALLIUM GA-68 RELITEGATIDE BREXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C195H288N54O51P3.Ga

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XQKHPHFSWXYCLX-SNFBFVMKSA-K

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C200464

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

168429490

Unique identification number in the NCBI database of chemical substances.

INN ID

13737

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(=O)N2CCC[C@@]2(C(=O)N([C@@H](CCCCNC(CCc3nnn(CCCNC(CCP(=O)(CN4CCN(CCN(CP(CCC(NCCCn5nnc(CCC(NCCCC[C@H]6C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](Cc7ccc(O)cc7)C(N8CCC[C@@]8(C(N6C)=O)[H])=O)=O)C)=O)CC(C)C)=O)CC(=O)O)=O)=O)CCCNC(=N)N)=O)Cc9ccc(O)cc9)=O)=O)c5)=O)(=O)[O-])CC4)CP(=O)([O-])CCC(=O)NCCCn%10cc(nn%10)CCC(=O)NCCCC[C@@H]%11N(C([C@]%12([H])N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC%11=O)Cc%13ccc(cc%13)O)=O)CCCNC(=N)N)=O)=O)CC(=O)O)=O)CC(C)C)=O)C)=O)Cc%14ccc(O)cc%14)=O)CCC%12)=O)C)[O-])=O)c3)=O)C(=O)N[C@@H](Cc%15ccc(cc%15)O)C(=O)N[C@H](C(NCC(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@H]1Cc%16ccc(O)cc%16)=O)=O)=O)CC(=O)O)=O)=O)CCCNC(=N)N)C)[H].[68Ga+3]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gallium Ga-68 Relitegatide Brexetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GALLIUM (68GA) RELITEGATIDE BREXETAN

Common Names & Synonyms

(68-GA)-TRIVEHEXIN

GALLIUM (68GA) RELITEGATIDE BREXETAN [INN]

GALLIUM GA-68 RELITEGATIDE BREXETAN

RELITEGATIDE BREXETAN GALLIUM GA-68

TRIVEHEXIN GA-68

Systematic Nomenclature

GALLATE(3-)-68GA, ((4,4',4''-((HEXAHYDRO-1H-1,4,7-TRIAZONINE-1,4,7-TRIYL-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7)TRIS(METHYLENE(PHOSPHINICO-.KAPPA.O)(1-OXO-3,1-PROPANEDIYL)IMINO-3,1-PROPANEDIYL-1H-1,2,3-TRIAZOL-1,4-DIYL(1-OXO-3,1-PROPANEDIYL)))TRIS(CYCLO(L-ALANYL-L-TYROSYL-D-PROLYL-N2-METHYL-L-LYSYL-L-TYROSYL-L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-L-LEUCYLATO)))(6-))-, HYDROGEN (1:3), (OC-6-22)-

SYS

External Clinical & Regulatory Resources

Previous UNII56V3OG5DC7

Next UNII56VY68111L